End-stage liver failure: filling the treatment gap at the intensive care unit.
Ontology highlight
ABSTRACT: End-stage liver failure is a condition of collapsing liver function with mortality rates up to 80. Liver transplantation is the only lifesaving therapy. There is an unmet need for therapy to extend the waiting time for liver transplantation or regeneration of the native liver. Here we review the state-of-the-art of non-cell based and cell-based artificial liver support systems, cell transplantation and plasma exchange, with the first therapy relying on detoxification, while the others aim to correct also other failing liver functions and/or modulate the immune response. Meta-analyses on the effect of non-cell based systems show contradictory outcomes for different types of albumin purification devices. For bioartificial livers proof of concept has been shown in animals with liver failure.
SUBMITTER: Chamuleau RAFM
PROVIDER: S-EPMC7228976 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA